QuestionSBA
QuestionChoice
This is a long-acting Beta-2 agonist and is prescribed once salbutamol and steroids have been trialled.
10004038
c
Salmeterol
QuestionChoice
This is an inhaled steroid. If short-acting beta-2 agonists are not a sufficient monotherapy in asthma, NICE recommends the addition of a steroid.
10004036
a
Beclomethasone
QuestionChoice
This is an anti-mucolytic agent used in the treatment of conditions such as chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis.
10004040
e
Carbocisteine
QuestionChoice
This is a short-acting muscarinic antagonist used first-line to treat patients with chronic obstructive pulmonary disease.
10004039
d
Ipratropium
QuestionChoice
This is a leukotriene receptor antagonist which is prescribed after short-acting and long-acting beta-2 agonists in adjunct with corticosteroids have failed to manage symptoms.
10004037
b
Montelukast
Concept
Chapter
2693
4228
Treatment options in Asthma
Topic
189
Respiratory Pharmacology
13354
A 12-year-old girl presents to the GP complaining of breathlessness and wheezing during light exercise. She uses her salbutamol inhaler but finds it is not helping.

Which of the following medications should be considered as the next line of management?
a